vs
Side-by-side financial comparison of Ceribell, Inc. (CBLL) and NEXPOINT DIVERSIFIED REAL ESTATE TRUST (NXDT). Click either name above to swap in a different company.
Ceribell, Inc. is the larger business by last-quarter revenue ($24.8M vs $18.4M, roughly 1.3× NEXPOINT DIVERSIFIED REAL ESTATE TRUST). Ceribell, Inc. runs the higher net margin — -54.6% vs -193.1%, a 138.5% gap on every dollar of revenue.
Ceribell, Inc. develops and commercializes innovative portable neurodiagnostic medical devices, focused on rapid non-invasive electroencephalogram (EEG) solutions for seizure detection. Its core products serve hospital emergency departments, intensive care units, and long-term care facilities, with primary markets across North America and ongoing global expansion efforts.
NexPoint Diversified Real Estate Trust is a publicly traded US real estate investment trust. It acquires, manages and optimizes a diversified portfolio covering multifamily housing, industrial facilities, offices and neighborhood retail, generating returns via rental income and long-term property value appreciation.
CBLL vs NXDT — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $24.8M | $18.4M |
| Net Profit | $-13.5M | $-35.5M |
| Gross Margin | 87.3% | — |
| Operating Margin | -58.9% | -18.8% |
| Net Margin | -54.6% | -193.1% |
| Revenue YoY | — | -29.0% |
| Net Profit YoY | — | -291.1% |
| EPS (diluted) | $-0.35 | $-0.73 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $24.8M | $18.4M | ||
| Q3 25 | $22.6M | $17.5M | ||
| Q2 25 | $21.2M | $21.0M | ||
| Q1 25 | $20.5M | $29.1M | ||
| Q4 24 | — | $25.9M | ||
| Q3 24 | $17.2M | $22.2M | ||
| Q2 24 | — | $22.3M | ||
| Q1 24 | — | $12.8M |
| Q4 25 | $-13.5M | $-35.5M | ||
| Q3 25 | $-13.5M | $-13.7M | ||
| Q2 25 | $-13.6M | $-45.3M | ||
| Q1 25 | $-12.8M | $-34.3M | ||
| Q4 24 | — | $-9.1M | ||
| Q3 24 | $-10.4M | $-10.0M | ||
| Q2 24 | — | $-9.8M | ||
| Q1 24 | — | $-22.7M |
| Q4 25 | 87.3% | — | ||
| Q3 25 | 88.3% | — | ||
| Q2 25 | 88.1% | — | ||
| Q1 25 | 87.9% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 87.3% | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | -58.9% | -18.8% | ||
| Q3 25 | -64.8% | -19.1% | ||
| Q2 25 | -70.5% | -0.6% | ||
| Q1 25 | -69.3% | 19.0% | ||
| Q4 24 | — | 3.6% | ||
| Q3 24 | -57.8% | -26.8% | ||
| Q2 24 | — | 2.7% | ||
| Q1 24 | — | 2.1% |
| Q4 25 | -54.6% | -193.1% | ||
| Q3 25 | -59.6% | -78.4% | ||
| Q2 25 | -64.4% | -215.1% | ||
| Q1 25 | -62.4% | -118.0% | ||
| Q4 24 | — | -35.0% | ||
| Q3 24 | -60.6% | -45.2% | ||
| Q2 24 | — | -43.9% | ||
| Q1 24 | — | -177.3% |
| Q4 25 | $-0.35 | $-0.73 | ||
| Q3 25 | $-0.37 | $-0.29 | ||
| Q2 25 | $-0.38 | $-0.99 | ||
| Q1 25 | $-0.36 | $-0.80 | ||
| Q4 24 | — | $-0.20 | ||
| Q3 24 | $-1.85 | $-0.25 | ||
| Q2 24 | — | $-0.24 | ||
| Q1 24 | — | $-0.59 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $159.3M | $8.2M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $155.3M | $700.1M |
| Total Assets | $195.8M | $1.1B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $159.3M | $8.2M | ||
| Q3 25 | $168.5M | $5.3M | ||
| Q2 25 | $177.4M | $4.7M | ||
| Q1 25 | $182.7M | $9.5M | ||
| Q4 24 | — | $8.8M | ||
| Q3 24 | $14.1M | $8.5M | ||
| Q2 24 | — | $28.4M | ||
| Q1 24 | — | $20.2M |
| Q4 25 | $155.3M | $700.1M | ||
| Q3 25 | $164.1M | $739.0M | ||
| Q2 25 | $172.2M | $752.7M | ||
| Q1 25 | $180.9M | $802.7M | ||
| Q4 24 | — | $836.5M | ||
| Q3 24 | $-136.0M | $842.9M | ||
| Q2 24 | — | $859.1M | ||
| Q1 24 | — | $863.0M |
| Q4 25 | $195.8M | $1.1B | ||
| Q3 25 | $199.5M | $1.1B | ||
| Q2 25 | $207.7M | $1.1B | ||
| Q1 25 | $213.5M | $1.2B | ||
| Q4 24 | — | $1.2B | ||
| Q3 24 | $47.1M | $1.2B | ||
| Q2 24 | — | $1.2B | ||
| Q1 24 | — | $1.1B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-10.8M | $9.2M |
| Free Cash FlowOCF − Capex | $-11.0M | — |
| FCF MarginFCF / Revenue | -44.2% | — |
| Capex IntensityCapex / Revenue | 0.7% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-41.6M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-10.8M | $9.2M | ||
| Q3 25 | $-11.1M | $835.0K | ||
| Q2 25 | $-7.5M | $75.0K | ||
| Q1 25 | $-11.4M | $7.1M | ||
| Q4 24 | — | $-11.7M | ||
| Q3 24 | — | $497.0K | ||
| Q2 24 | — | $-5.5M | ||
| Q1 24 | — | $-2.6M |
| Q4 25 | $-11.0M | — | ||
| Q3 25 | $-11.5M | — | ||
| Q2 25 | $-7.6M | — | ||
| Q1 25 | $-11.6M | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | -44.2% | — | ||
| Q3 25 | -50.8% | — | ||
| Q2 25 | -35.9% | — | ||
| Q1 25 | -56.4% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | 0.7% | — | ||
| Q3 25 | 1.6% | — | ||
| Q2 25 | 0.3% | — | ||
| Q1 25 | 0.7% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CBLL
| Products | $18.8M | 76% |
| Subscription | $6.0M | 24% |
NXDT
Segment breakdown not available.
